Results and prospects of development of new polyphenolic drugs for cancer patients

Vladimir N. Anisimov; Stig Larsen; Stig Lofberg; Irina A. Baldueva; Anastasia V. Malek; Tea Kirkegaard Nielsen; Elena I. Fedoros; Irina V. Perminova; Evgeny Yu Drobyshev; Vladimir N. Bykov; Andrey V. Panchenko; Alexander M. Scherbakov; Alexey M. Belyaev

doi:10.18632/oncotarget.22307

Results and prospects of development of new polyphenolic drugs for cancer patients

Vladimir N. Anisimov^*, Stig Larsen, Stig Lofberg, Irina A. Baldueva, Anastasia V. Malek, Tea Kirkegaard Nielsen, Elena I. Fedoros, Irina V. Perminova, Evgeny Yu Drobyshev, Vladimir N. Bykov, Andrey V. Panchenko, Alexander M. Scherbakov, Alexey M. Belyaev

^*Corresponding author for this work

5 Citations (Scopus)

59 Downloads (Pure)

Abstract

The conference "Results and prospects of development of new polyphenolic drugs for cancer patients" took place at the N.N. Petrov National Medical Research Center of Oncology (PNMRCO) on May 31, 2017, and gathered researchers involved in development and evaluation of medicinal products based on the novel lignin-derived soluble polyphenolic polymer BP-Cx-1. BP-Cx-1 is the platform for a portfolio of innovative pharmacological products such as BP-C1, BP-C2 and BP-C3.

Original language	English
Journal	OncoTarget
Volume	8
Issue number	59
Pages (from-to)	100951-100956
Number of pages	6
ISSN	1949-2553
DOIs	https://doi.org/10.18632/oncotarget.22307
Publication status	Published - 2017

Keywords

Breast cancer
Cancer
Cancer chemotherapy
Clinical trial
Polyphenols

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.18632/oncotarget.22307Licence: CC BY

Results and prospects of development of new polyphenolic drugs for cancer patientsFinal published version, 621 KBLicence: CC BY

Cite this

Anisimov, V. N., Larsen, S., Lofberg, S., Baldueva, I. A., Malek, A. V., Nielsen, T. K., Fedoros, E. I., Perminova, I. V., Drobyshev, E. Y., Bykov, V. N., Panchenko, A. V., Scherbakov, A. M., & Belyaev, A. M. (2017). Results and prospects of development of new polyphenolic drugs for cancer patients. OncoTarget, 8(59), 100951-100956. https://doi.org/10.18632/oncotarget.22307

@article{2b017d53d0ed49b5bde1ac737aeb4769,

title = "Results and prospects of development of new polyphenolic drugs for cancer patients",

abstract = "The conference {"}Results and prospects of development of new polyphenolic drugs for cancer patients{"} took place at the N.N. Petrov National Medical Research Center of Oncology (PNMRCO) on May 31, 2017, and gathered researchers involved in development and evaluation of medicinal products based on the novel lignin-derived soluble polyphenolic polymer BP-Cx-1. BP-Cx-1 is the platform for a portfolio of innovative pharmacological products such as BP-C1, BP-C2 and BP-C3.",

keywords = "Breast cancer, Cancer, Cancer chemotherapy, Clinical trial, Polyphenols",

author = "Anisimov, {Vladimir N.} and Stig Larsen and Stig Lofberg and Baldueva, {Irina A.} and Malek, {Anastasia V.} and Nielsen, {Tea Kirkegaard} and Fedoros, {Elena I.} and Perminova, {Irina V.} and Drobyshev, {Evgeny Yu} and Bykov, {Vladimir N.} and Panchenko, {Andrey V.} and Scherbakov, {Alexander M.} and Belyaev, {Alexey M.}",

year = "2017",

doi = "10.18632/oncotarget.22307",

language = "English",

volume = "8",

pages = "100951--100956",

journal = "Oncotarget",

issn = "1949-2553",

publisher = "Impact Journals LLC",

number = "59",

}

TY - JOUR

T1 - Results and prospects of development of new polyphenolic drugs for cancer patients

AU - Anisimov, Vladimir N.

AU - Larsen, Stig

AU - Lofberg, Stig

AU - Baldueva, Irina A.

AU - Malek, Anastasia V.

AU - Nielsen, Tea Kirkegaard

AU - Fedoros, Elena I.

AU - Perminova, Irina V.

AU - Drobyshev, Evgeny Yu

AU - Bykov, Vladimir N.

AU - Panchenko, Andrey V.

AU - Scherbakov, Alexander M.

AU - Belyaev, Alexey M.

PY - 2017

Y1 - 2017

N2 - The conference "Results and prospects of development of new polyphenolic drugs for cancer patients" took place at the N.N. Petrov National Medical Research Center of Oncology (PNMRCO) on May 31, 2017, and gathered researchers involved in development and evaluation of medicinal products based on the novel lignin-derived soluble polyphenolic polymer BP-Cx-1. BP-Cx-1 is the platform for a portfolio of innovative pharmacological products such as BP-C1, BP-C2 and BP-C3.

AB - The conference "Results and prospects of development of new polyphenolic drugs for cancer patients" took place at the N.N. Petrov National Medical Research Center of Oncology (PNMRCO) on May 31, 2017, and gathered researchers involved in development and evaluation of medicinal products based on the novel lignin-derived soluble polyphenolic polymer BP-Cx-1. BP-Cx-1 is the platform for a portfolio of innovative pharmacological products such as BP-C1, BP-C2 and BP-C3.

KW - Breast cancer

KW - Cancer

KW - Cancer chemotherapy

KW - Clinical trial

KW - Polyphenols

U2 - 10.18632/oncotarget.22307

DO - 10.18632/oncotarget.22307

M3 - Comment/debate

AN - SCOPUS:85034664311

SN - 1949-2553

VL - 8

SP - 100951

EP - 100956

JO - Oncotarget

JF - Oncotarget

IS - 59

ER -

Results and prospects of development of new polyphenolic drugs for cancer patients

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this